|By PR Newswire||
|January 7, 2013 08:37 AM EST||
LAS VEGAS, Jan. 7, 2013 /PRNewswire/ -- Asthmapolis today announced that founder and CEO David Van Sickle will discuss innovations in mobile health, medical devices and the cloud in a keynote panel at the Consumer Electronics Show (CES) this week in Las Vegas, Nevada.
The panel, "Why Healthcare Has Its Head in the Cloud," brings together industry pioneers to discuss how the cloud is breaking down barriers and empowering communication among mobile apps, EMRs and medical devices, literally liberating the data for better patient outcomes.
"2013 is going to be a turning point for digital health, so I'm delighted to join this panel to talk about the promise of mobile and cloud based technologies in healthcare," said Van Sickle. "With a record number of medical devices and apps being showcased at CES, it's clear that the Digital Health Summit is harnessing the momentum of this exciting movement."
The keynote luncheon will take place Thursday, January 10, 2013 at 1:00 p.m. at the Las Vegas Convention Center, hall N250. For more information, visit http://ces13.mapyourshow.com/5_0/sessions/sessiondetails.cfm?ScheduledSessionID=1AA8CA.
With more than four decades of success, the International Consumer Electronics Show (CES) reaches across global markets, connects the industry and enables CE innovations to grow and thrive. The International CES is owned and produced by the Consumer Electronics Association (CEA), the preeminent trade association promoting growth in the $195 billion U.S. consumer electronics industry.
About Van Sickle
David Van Sickle is a PhD asthma epidemiologist formerly at CDC where he was in charge of asthma outbreak investigations. The lack of data on what might be triggering these outbreaks was the inspiration for Asthmapolis. David is also an expert and very well connected in the mobile health (mHealth) and quantified self communities, as well as in federal agencies such as CDC and HHS.
Asthmapolis was founded in 2010 with the goal of improving the management of asthma for patients and healthcare professionals. The company's inhaler sensors, mobile applications and other tools enable asthma patients and their physicians to gain more awareness of asthma control and understanding of triggers, while also providing public health researchers with timely, comprehensive and objective data on the burden of asthma in communities. Asthmapolis has partnered with organizations such as the Air Pollution and Respiratory Health Branch at the U.S. Centers for Disease Control and Prevention, the California HealthCare Foundation, Dignity Health and others. For more information, please visit www.asthmapolis.com.
Media contact: Erica St. Angel, [email protected], 608-251-0470